Recombinant Bacteroides thetaiotaomicron Altronate oxidoreductase (uxaB)

Shipped with Ice Packs
In Stock

Description

Contextual Overview of Altronate Oxidoreductase (UxaB)

Altronate oxidoreductase (EC 1.1.1.58) is an enzyme that catalyzes the conversion of D-altronate to 2-keto-3-deoxy-D-gluconate (KDG) in the uronic acid degradation pathway. In Escherichia coli, uxaB operates within the galacturonate/altronate utilization pathway, which is critical for metabolizing plant-derived pectin[^1^][^2^]. While B. thetaiotaomicron is known for its extensive glycan degradation capabilities, the uxaB homolog has not been characterized in this organism within the provided sources.

Potential Metabolic Role in B. thetaiotaomicron

The glucuronate utilization pathway in B. thetaiotaomicron involves the BT1434-BT1432 operon , which is regulated by the transcriptional activator BT4338. This operon may include genes analogous to uxaB, though no direct evidence links it to altronate metabolism. Key findings from related pathways include:

  • BT4338-dependent activation: Genes involved in glucuronate utilization are upregulated during carbon limitation .

  • Oxidative stress interplay: Enzymes like pyruvate:ferredoxin oxidoreductase (PFOR) are modulated during carbohydrate metabolism, influencing ROS production .

Comparative Genomic Insights

While uxaB is absent from the provided data, other B. thetaiotaomicron enzymes involved in carbohydrate metabolism include:

EnzymeFunctionRelevance to UxaB
Xylose isomerase (BT0791-BT0794) Converts xylose to xylulosePart of xylose utilization operon
Arylsulfatase (BT1636) Cleaves sulfate groups from glycansCritical for mucin degradation
NQR complex (BT1155-BT1160) Regulates NAD+ regeneration and OMV biogenesisIndirectly modulates immunomodulation

Hypothetical Regulatory Framework

If uxaB exists in B. thetaiotaomicron, its regulation might align with:

  • BT4338-dependent activation: Similar to glucuronate/xylose operons .

  • Post-transcriptional control: RNA-binding proteins like RbpB and sRNAs (e.g., FopS) could fine-tune its expression .

Research Gaps and Future Directions

  1. Gene annotation: The uxaB homolog (if present) remains uncharacterized in B. thetaiotaomicron.

  2. Functional studies: Heterologous expression and enzymatic assays are needed to confirm activity.

  3. Metabolic flux analysis: Determine whether altronate is a substrate for B. thetaiotaomicron in gut environments.

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during the production process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
uxaB; BT_0825; Altronate oxidoreductase; EC 1.1.1.58; Tagaturonate dehydrogenase; Tagaturonate reductase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-479
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / NCTC 10582 / E50 / VPI-5482)
Target Names
uxaB
Target Protein Sequence
MKALNKETAP KVQRPERIIQ FGEGNFLRAF VDWIIYNMNQ KTDFNSSVVV VQPIDKGMVD MLNAQDDLYH VNLQGLDKGE VVNSLTMIDV ISRALNPYTQ NDEFMKLAEQ PEMRFVISNT TEAGIAFDPT CKLEDAPASS YPGKLTQLLY HRFKTFNGDK TKGLIIFPCE LIFLNGHKLK ETIYQYIDLW NLGNEFKTWF EEACGVYATL VDRIVPGFPR KDIAAIKEKI QYDDNLVVQA EIFHLWVIEA PQEVAKEFPA DKAGLNVLFV PSEAPYHERK VTLLNGPHTV LSPVAYLSGV NIVRDACQHE VIGKYIHKVM FDELMETLNL PKEELKKFAE DVLERFNNPF VDHAVTSIML NSFPKYETRD LPGLKTYLER KGELPKGLVL GLAAIITYYK GGVRADGAEI VPNDAPEIMN LLKELWATGC TKKVTEGVLA AEFIWGEDLN KIPGLAAAVK ADLDSIQEKG MLETVKGIL
Uniprot No.

Q&A

What is Altronate Oxidoreductase (uxaB) and its functional role in Bacteroides thetaiotaomicron?

Altronate oxidoreductase (uxaB) in Bacteroides thetaiotaomicron is an enzyme involved in the hexuronate metabolism pathway, specifically catalyzing the conversion of D-altronate to D-tagaturonate. This oxidoreduction reaction is crucial for the bacterium's ability to metabolize certain carbohydrates in the gut environment. The enzyme functions within anaerobic conditions typical of the gut microbiota, where B. thetaiotaomicron normally resides. Understanding this enzyme's activity provides insights into how this important gut symbiont processes specific carbon sources, contributing to its ecological role in the microbiome .

What growth conditions are optimal for expressing recombinant B. thetaiotaomicron proteins?

For optimal expression of recombinant proteins such as uxaB in B. thetaiotaomicron, researchers should consider several key growth parameters. The bacterium grows well in media containing rumen fluid (up to 75%) or high concentrations of volatile fatty acids (total concentration of approximately 100 mmol l-1) under strictly anaerobic conditions . For laboratory culture, cells can be incubated under anaerobic conditions in BHI (Brain Heart Infusion) medium until logarithmic phase (OD600 = 0.6–0.8) before transfer to deoxygenated defined media for experimental procedures . When working with recombinant strains, maintaining selection pressure through appropriate antibiotics is essential to prevent plasmid loss during cultivation.

What methods are recommended for extracting and purifying recombinant uxaB from B. thetaiotaomicron?

For effective extraction and purification of recombinant uxaB from B. thetaiotaomicron, the following methodological approach is recommended:

  • Culture cells to logarithmic phase (OD600 = 0.6–0.8) in appropriate anaerobic media

  • Harvest cells by centrifugation at 8,000 rpm for 5 minutes at 4°C

  • Resuspend cell pellet in an appropriate buffer containing protease inhibitors

  • Lyse cells using methods suitable for anaerobic bacteria, such as lysozyme treatment (10 mg/mL) followed by homogenization

  • Clarify the lysate by centrifugation to remove cell debris

  • Proceed with protein purification using affinity chromatography (if the recombinant protein contains an affinity tag)

  • Further purify using ion exchange and/or size exclusion chromatography if higher purity is required

  • Verify protein identity and purity using SDS-PAGE and Western blotting

Storage of purified enzyme should be under anaerobic conditions with appropriate stabilizing agents to preserve enzymatic activity.

How can researchers establish a reliable expression system for recombinant uxaB in B. thetaiotaomicron?

Establishing a reliable expression system for recombinant uxaB in B. thetaiotaomicron requires strategic planning and consideration of several key factors:

  • Vector Selection and Construction:

    • Select a suitable vector with compatibility for B. thetaiotaomicron

    • Consider vectors with inducible promoters for controlled expression

    • Design the construct to include appropriate restriction sites for cloning

    • Include a sequence encoding an affinity tag for purification purposes

  • Transformation Method:

    • For B. thetaiotaomicron, conjugation from E. coli S17-1 is often effective

    • Select appropriate antibiotic markers for selection of transformants

    • Verify successful transformation using colony PCR or restriction analysis

  • Promoter Selection:

    • The use of native B. thetaiotaomicron promoters can enhance expression

    • Consider using promoters like PsusA or similar promoters known to function well in this organism

    • For uxaB specifically, consider using its native promoter or a regulated promoter if controlled expression is desired

  • Expression Verification:

    • Confirm expression using RT-qPCR for transcript levels

    • Verify protein production using Western blotting

    • Assess enzymatic activity using specific assays for altronate oxidoreductase

The successful implementation of this expression system should be validated through multiple independent transformations and expression analyses to ensure reproducibility.

What analytical methods are most appropriate for measuring uxaB enzyme activity?

For accurate measurement of altronate oxidoreductase (uxaB) activity, researchers should consider implementing the following analytical approaches:

Analytical MethodApplicationAdvantagesLimitations
Spectrophotometric AssayPrimary activity measurementReal-time kinetics, quantitativePotential interference from cell extracts
HPLC AnalysisProduct/substrate quantificationHigh sensitivity, separation capabilityTime-consuming, requires specialized equipment
Coupled Enzyme AssaysIndirect activity measurementEnhanced sensitivityDependent on secondary enzyme reliability
Mass SpectrometryProduct identification/quantificationHighest specificity and sensitivityExpensive, requires technical expertise

The spectrophotometric assay typically monitors NAD(P)H oxidation or reduction at 340 nm, reflecting the oxidoreductase activity. For reliable results, researchers should include appropriate controls, standardize reaction conditions (pH, temperature, substrate concentration), and validate assay linearity within their working range. Additionally, oxygen exposure should be minimized during enzyme preparation and assay performance as B. thetaiotaomicron is an anaerobic organism and its enzymes may be oxygen-sensitive .

How can researchers effectively assay the survival and stability of recombinant B. thetaiotaomicron strains expressing uxaB?

To effectively assay the survival and stability of recombinant B. thetaiotaomicron strains expressing uxaB, researchers should implement a comprehensive approach that addresses both viability and genetic stability:

  • Viability Assessment:

    • Culture cells to logarithmic phase under anaerobic conditions

    • Transfer to experimental conditions (e.g., varying oxygen exposure, pH, temperature)

    • Monitor growth by measuring OD600 periodically

    • Determine viable counts through serial dilution and plating on selective media

    • Calculate survival rates by comparing pre- and post-exposure colony forming units (CFUs)

  • Genetic Stability Evaluation:

    • Maintain cultures through multiple generations (minimum 10-15)

    • Periodically sample to verify uxaB gene retention via PCR

    • Assess protein expression stability through Western blotting

    • Measure enzyme activity to confirm functional stability

    • Sequence the uxaB gene after multiple generations to detect potential mutations

  • Environmental Stress Testing:

    • Evaluate strain performance under various stressors (e.g., oxidative stress using H2O2)

    • Create inhibition zone assays using varied concentrations of stressors

    • Measure zones of inhibition using calibrated instruments such as vernier calipers

    • Compare stress responses between wild-type and recombinant strains

For long-term experiments, a consecutive batch culture (CBC) system can be particularly valuable, allowing for the assessment of competitive fitness in complex microbial communities, mimicking natural environments such as the gut or rumen .

What strategies can be employed to enhance uxaB expression and stability in recombinant B. thetaiotaomicron?

Enhancing uxaB expression and stability in recombinant B. thetaiotaomicron requires a multifaceted approach targeting genetic, metabolic, and environmental factors:

  • Genetic Optimization Strategies:

    • Codon optimization based on B. thetaiotaomicron's preferred codon usage

    • Use of strong, constitutive promoters or inducible systems like the rhaR system

    • Incorporation of transcriptional terminators to prevent read-through

    • Addition of stabilizing sequences to enhance mRNA stability

    • Engineering fusion partners or solubility tags if protein aggregation occurs

  • Metabolic Engineering Approaches:

    • Co-expression of chaperones to assist proper protein folding

    • Modification of carbon source availability to enhance expression

    • Supplementation with specific metabolites that serve as enzyme cofactors

    • Regulation of competing metabolic pathways to direct resources toward uxaB production

  • Environmental and Culture Condition Optimization:

    • Precise control of anaerobic conditions (O2 < 0.1 ppm)

    • Supplementation with growth-promoting substrates like chondroitin sulfate

    • Optimization of culture density and growth phase for harvesting

    • Temperature and pH optimization for maximal enzyme stability

    • Development of fed-batch or continuous culture systems for long-term production

Researchers should employ a systematic approach to optimization, utilizing design of experiments (DOE) methodology to efficiently identify optimal conditions while minimizing experimental runs. Regular monitoring of genetic stability through multiple generations remains essential to ensure consistent expression over time.

How does oxidative stress affect recombinant uxaB expression and function in B. thetaiotaomicron?

Oxidative stress significantly impacts both the expression and functional activity of recombinant altronate oxidoreductase (uxaB) in B. thetaiotaomicron due to the organism's strict anaerobic nature. Research indicates several key effects and potential adaptation mechanisms:

  • Direct Effects on Enzyme Structure and Function:

    • Oxygen exposure can lead to oxidation of critical thiol groups in the enzyme

    • Structural changes may occur, altering substrate binding capacity

    • Loss of catalytic activity through cofactor oxidation or displacement

    • Potential protein aggregation under oxidative conditions

  • Effects on Expression Systems:

    • Oxidative stress activates stress response pathways that may repress heterologous gene expression

    • Redirection of cellular resources toward stress response rather than recombinant protein production

    • Metabolic shifts that alter the availability of substrates and cofactors needed for enzyme function

  • Adaptive Responses and Protection Strategies:

    • B. thetaiotaomicron demonstrates some capacity to adapt to brief oxygen exposure through specific metabolic pathways

    • Pre-conditioning in specific media compositions (DMG vs. DMR) affects oxidative stress tolerance

    • Gene expression patterns change significantly during aerobic-anaerobic transitions, with potential implications for recombinant protein expression

Researchers investigating recombinant uxaB should consider implementing protection strategies such as inclusion of reducing agents in buffers, strict anaerobic handling protocols, and potentially engineering oxidative stress resistance into their expression strains. The development of experimental designs that account for these effects is critical for obtaining reliable and reproducible results .

What transcriptomic and proteomic approaches can reveal regulatory networks affecting uxaB expression?

Understanding the regulatory networks governing uxaB expression requires sophisticated transcriptomic and proteomic approaches. Researchers can implement the following methodological strategies:

  • Transcriptomic Analysis:

    • RNA-Seq to identify differentially expressed genes under varying conditions

    • RT-qPCR for targeted validation of key gene expression patterns

    • Transcription start site (TSS) mapping to identify promoter regions

    • RNA stability assays to determine post-transcriptional regulation

    Methodology Note: For RNA extraction from B. thetaiotaomicron, resuspend cells in 100 μL of 10 mg/mL lysozyme, homogenize, and use a total RNA isolation kit. After quality checks and DNase treatment, synthesize cDNA using reverse transcriptase for subsequent analysis .

  • Proteomic Analysis:

    • Label-free quantitative proteomics to identify protein abundance changes

    • Phosphoproteomics to detect regulatory post-translational modifications

    • Protein-protein interaction studies using pull-down assays or crosslinking

    • Activity-based protein profiling to identify functionally relevant proteins

  • Integrative Multi-omics Approaches:

    • Integration of transcriptomic and proteomic datasets to identify correlations and discrepancies

    • Metabolomic analysis to connect enzymatic activities with metabolite profiles

    • Network analysis to reconstruct regulatory pathways

    • Comparative analysis across different growth conditions and genetic backgrounds

Data TypePrimary ApplicationKey Analysis MethodExpected Outcome
TranscriptomeGene expression changesDifferential expression analysisIdentification of co-regulated genes
ProteomeProtein abundanceQuantitative comparisonPost-transcriptional regulation insights
PhosphoproteomeSignaling networksPhosphosite identificationRegulatory mechanism discovery
MetabolomePathway activityMetabolic flux analysisFunctional impacts of uxaB activity

For analyzing complex datasets, researchers should employ statistical methods appropriate for multi-omics data, including multivariate analysis, clustering algorithms, and pathway enrichment tools. The 2−ΔΔCt method is appropriate for analyzing RT-qPCR data when evaluating relative gene expression levels .

What are the most effective genetic engineering strategies for improving uxaB functional expression?

Effective genetic engineering of uxaB for improved functional expression in B. thetaiotaomicron can be achieved through several strategic approaches:

  • Promoter Engineering:

    • Testing and optimization of native B. thetaiotaomicron promoters

    • Development of synthetic promoters with enhanced strength and inducibility

    • Creation of hybrid promoters combining beneficial elements from different sources

    • Implementation of regulated expression systems like the rhaR system adapted for B. thetaiotaomicron

  • Gene and Protein Modifications:

    • Codon optimization tailored to B. thetaiotaomicron's codon usage preferences

    • Introduction of strategically placed affinity tags for purification without activity loss

    • Engineering solubility-enhancing mutations or domains

    • Removal of cryptic splice sites or regulatory elements that might interfere with expression

  • Vector Design Considerations:

    • Selection of appropriate origin of replication for stable maintenance

    • Incorporation of selectable markers compatible with B. thetaiotaomicron

    • Careful design of multiple cloning sites for flexible construct assembly

    • Inclusion of transcriptional terminators to prevent read-through

  • Delivery and Integration Methods:

    • Optimization of conjugation protocols for plasmid transfer from E. coli S17-1

    • Development of direct transformation methods

    • Creation of integrative vectors for chromosomal insertion and stable expression

    • Exploration of CRISPR-Cas9 systems adapted for B. thetaiotaomicron genome editing

These strategies should be systematically evaluated using standardized assays for enzyme activity, protein solubility, and expression level to identify the most effective combination for any specific research application.

How can researchers design assays to evaluate uxaB substrate specificity and kinetic parameters?

Designing robust assays to evaluate uxaB substrate specificity and kinetic parameters requires careful consideration of enzyme characteristics, reaction conditions, and detection methods:

  • Substrate Specificity Assessment:

    • Prepare a panel of structurally related substrates (altronate analogs and related sugar acids)

    • Develop a primary screening assay using spectrophotometric detection of NAD(P)H

    • Confirm activity with promising substrates using secondary assays (HPLC or LC-MS)

    • Determine relative activity across substrate panel under standardized conditions

  • Kinetic Parameter Determination:

    • Establish initial velocity conditions through time-course experiments

    • Determine Michaelis-Menten parameters (Km, Vmax) using varying substrate concentrations

    • Evaluate potential inhibitors and their inhibition constants (Ki)

    • Assess the effects of pH, temperature, and ionic strength on kinetic parameters

  • Methodology Considerations:

    • Maintain strict anaerobic conditions throughout assay procedures

    • Use appropriate buffer systems that maintain pH stability

    • Include controls for spontaneous substrate degradation or product formation

    • Employ internal standards for quantitative analyses

  • Data Analysis Approaches:

    • Fit kinetic data to appropriate models using non-linear regression

    • Compare substrate preference using specificity constants (kcat/Km)

    • Analyze pH and temperature profiles to identify optimal conditions

    • Apply statistical methods to validate significance of observed differences

For accurate kinetic measurements, researchers should ensure that enzyme preparations are of high purity and properly folded. Activity measurements should be made in the linear range of both enzyme concentration and reaction time. When working with oxygen-sensitive enzymes like those from B. thetaiotaomicron, specialized anaerobic chambers or cuvettes should be employed to prevent oxidative inactivation during measurements .

What novel biocontainment strategies should be considered when working with recombinant B. thetaiotaomicron strains?

When developing and working with recombinant B. thetaiotaomicron strains expressing uxaB, researchers must implement appropriate biocontainment strategies to prevent unintended environmental release and proliferation:

  • Genetic Containment Approaches:

    • Auxotrophy-based containment systems requiring non-natural supplements

    • Genetic circuits that couple survival to specific inducers absent in natural environments

    • Engineered dependency on synthetic amino acids or nucleotides

    • Development of genetic kill switches activated by environmental conditions

    • Implementation of multiple, independent containment mechanisms to prevent escape through mutation

  • Physical Containment Methods:

    • Strict adherence to BSL-2 practices for handling recombinant anaerobes

    • Use of specialized anaerobic chambers with HEPA filtration

    • Implementation of dedicated equipment and areas for recombinant work

    • Proper waste treatment procedures for all materials contacting cultures

  • Ecological Containment Considerations:

    • Design of strains with reduced fitness in natural environments

    • Experimental assessment of survival rates under various conditions

    • Competitive fitness evaluations using systems like consecutive batch cultures (CBC)

    • Development of strains that cannot transfer recombinant elements to other organisms

Research has demonstrated that even engineered B. thetaiotaomicron strains exhibit limited persistence in competitive environments without specific supportive factors. For instance, studies with recombinant strain BTX showed rapid decline in competitive batch cultures unless supplemented with specific substrates like chondroitin sulfate, and even then maintained at relatively low levels (approximately 10^5 cells/ml) . These natural limitations can be leveraged and enhanced through genetic engineering to ensure appropriate biocontainment.

How should researchers approach data analysis for complex enzyme kinetics of uxaB?

Analyzing complex enzyme kinetics for altronate oxidoreductase (uxaB) requires sophisticated approaches to account for various factors affecting enzymatic behavior:

  • Model Selection and Validation:

    • Begin with standard Michaelis-Menten analysis for initial characterization

    • Progress to more complex models (substrate inhibition, allosteric regulation) if data deviates from simple kinetics

    • Utilize information criteria (AIC, BIC) to select the most appropriate model

    • Validate models using residual analysis and parameter confidence intervals

  • Handling Non-linear Behaviors:

    • Apply specialized software packages for enzyme kinetics (e.g., DynaFit, KinTek Explorer)

    • Implement global fitting approaches for complex reaction mechanisms

    • Consider Bayesian methods for parameter estimation with uncertain data

    • Develop custom models when standard equations do not apply

  • Statistical Approaches:

    • Utilize weighted regression when measurement errors vary with substrate concentration

    • Perform outlier detection and robust regression when appropriate

    • Implement bootstrapping techniques to estimate parameter uncertainty

    • Apply ANOVA or similar statistical tests when comparing enzymes across conditions

  • Visualization Techniques:

    • Create Lineweaver-Burk, Eadie-Hofstee, or Hanes-Woolf plots for diagnostic purposes

    • Develop 3D surface plots for displaying multi-parameter dependencies

    • Utilize residual plots to identify systematic deviations from models

    • Create comparative kinetic profiles across experimental conditions

Researchers should prepare data tables that organize experimental results systematically, similar to the approach described for presenting qualitative research data . For complex kinetic analyses, incorporate appropriate statistical measures and clearly describe the modeling approach used to derive kinetic parameters.

What approaches help resolve contradictory results when studying uxaB in different experimental systems?

When facing contradictory results in uxaB studies across different experimental systems, researchers should implement a systematic troubleshooting and reconciliation approach:

  • Systematic Variation Analysis:

    • Identify all variables differing between experimental systems (media composition, oxygen exposure, strain background, etc.)

    • Systematically test each variable to determine its contribution to observed differences

    • Create a matrix experimental design to identify potential interaction effects

    • Implement standardized protocols across research groups when possible

  • Technical Validation Steps:

    • Cross-validate analytical methods between different systems

    • Perform spike-recovery experiments to test for matrix effects

    • Exchange critical reagents (enzymes, substrates, cell lines) between laboratories

    • Implement blinded analysis to eliminate observer bias

  • Biological Source Considerations:

    • Verify the genetic integrity of strains through sequencing

    • Assess potential differences in post-translational modifications

    • Consider the impact of growth phase and cell density on enzyme activity

    • Evaluate the influence of oxygen exposure during experimental procedures

  • Data Integration Approaches:

    • Develop mathematical models that can accommodate different experimental contexts

    • Use meta-analysis techniques to identify consistent patterns across studies

    • Implement Bayesian approaches to update confidence in results as new data emerges

    • Create consensus frameworks that explain apparent contradictions

A particularly useful approach is to organize findings in concept-evidence tables or cross-case analysis tables that systematically compare results across different experimental systems, highlighting where consistencies and inconsistencies occur . This structured comparison can reveal patterns not obvious in narrative descriptions.

How can researchers effectively document and report experimental conditions for uxaB studies to ensure reproducibility?

Ensuring reproducibility in uxaB studies requires comprehensive documentation and reporting of experimental conditions following these methodological guidelines:

  • Detailed Materials and Methods Documentation:

    • Provide complete strain information including source, genotype, and verification methods

    • Document exact media composition with precise concentrations and preparation methods

    • Report all growth conditions with specific parameters (temperature, pH, O2 levels, agitation rate)

    • Describe enzyme purification protocols with buffer compositions and storage conditions

    • Specify analytical equipment models, settings, and calibration procedures

  • Standardized Reporting Formats:

    • Follow field-specific reporting guidelines for enzymatic studies

    • Organize methodology details in clearly structured sections as outlined in research methodology guidance

    • Present experimental designs in tabular formats for clarity

    • Document any deviations from standard protocols with justifications

  • Critical Parameters Reporting:

    • For anaerobic work, precisely describe methods for establishing and verifying anaerobiosis

    • Report oxygen exposure times if samples were handled outside anaerobic conditions

    • Document cell growth phases at harvest (OD600 measurements)

    • Report batch-to-batch variation in enzyme preparations

    • Include negative and positive controls used in all experiments

  • Data Transparency Practices:

    • Provide raw data in supplementary materials or data repositories

    • Share detailed protocols through protocol repositories

    • Document software versions and parameters used for data analysis

    • Present both successful and failed experimental approaches

Table formats particularly useful for documenting uxaB research include data inventory tables, data sources tables, data analysis tables, and event listing tables to capture chronological sequences of experimental procedures . These structured formats enhance clarity and facilitate reproduction by other researchers.

What are the promising applications of engineered B. thetaiotaomicron strains expressing modified uxaB?

Engineered Bacteroides thetaiotaomicron strains with modified altronate oxidoreductase (uxaB) present several promising research avenues:

  • Gut Microbiome Engineering:

    • Development of engineered probiotics with enhanced carbohydrate utilization capabilities

    • Creation of diagnostic strains that produce signals when exposed to specific gut conditions

    • Design of therapeutic strains for targeted delivery of bioactive compounds to the intestine

    • Engineering ecological niche expansion through novel metabolic capabilities

  • Fundamental Understanding of Oxidoreductases:

    • Structure-function relationship studies through systematic protein engineering

    • Investigation of enzyme evolution through ancestral sequence reconstruction

    • Exploration of substrate promiscuity and potential for novel reactions

    • Study of protein-protein interactions in metabolic pathway channeling

  • Biotechnological Applications:

    • Development of whole-cell biocatalysts for sugar acid transformations

    • Creation of biosensors for detecting specific carbohydrates in complex mixtures

    • Engineering of strains for production of value-added compounds from waste biomass

    • Design of anaerobic enzyme cascades for in vitro biocatalysis

  • Host-Microbe Interaction Studies:

    • Investigation of how modified metabolic capabilities affect host physiology

    • Exploration of immune system interactions with engineered strains

    • Study of colonization dynamics with metabolically enhanced strains

    • Assessment of competitive fitness in complex microbial communities

The potential for manipulation of rumen function through engineered B. thetaiotaomicron, as discussed in previous research , represents just one example of the broader applications possible with engineered versions of this important gut symbiont.

What emerging technologies might advance our understanding of uxaB structure-function relationships?

Several emerging technologies show significant promise for advancing our understanding of uxaB structure-function relationships:

  • Advanced Structural Biology Techniques:

    • Cryo-electron microscopy for high-resolution protein structures without crystallization

    • Microcrystal electron diffraction (MicroED) for structural analysis of small crystals

    • Time-resolved X-ray crystallography to capture enzyme conformational changes

    • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) for mapping protein dynamics

    • Integrative structural biology combining multiple experimental approaches

  • Computational Advances:

    • Artificial intelligence approaches for protein structure prediction (AlphaFold-type systems)

    • Molecular dynamics simulations of enzyme-substrate interactions in explicit solvent

    • Quantum mechanics/molecular mechanics (QM/MM) simulations of reaction mechanisms

    • Deep learning for predicting effects of mutations on enzyme function

    • In silico enzyme design for novel activities or improved stability

  • High-throughput Functional Analysis:

    • Droplet microfluidics for single-variant enzyme kinetics

    • Deep mutational scanning to comprehensively map sequence-function relationships

    • Activity-based protein profiling for functional proteomics

    • Automated enzyme assay platforms for rapid kinetic characterization

    • Multiplexed assays for simultaneous testing of multiple variants

  • Single-molecule Techniques:

    • Single-molecule FRET to track conformational changes during catalysis

    • Optical tweezers or atomic force microscopy for measuring enzyme-substrate interactions

    • Nanopore-based approaches for monitoring individual enzyme reaction cycles

    • Zero-mode waveguides for observing single-molecule reactions in real-time

These technologies, when applied to uxaB research, will provide unprecedented insights into how this enzyme functions at the molecular level, potentially enabling rational design of variants with enhanced or novel functions for both fundamental research and biotechnological applications.

How might systems biology approaches enhance understanding of uxaB's role in B. thetaiotaomicron metabolism?

Systems biology approaches offer powerful frameworks for contextualizing uxaB within the broader metabolic network of B. thetaiotaomicron:

  • Genome-scale Metabolic Modeling:

    • Development of comprehensive metabolic reconstructions incorporating uxaB-related pathways

    • Flux balance analysis to predict metabolic shifts under various conditions

    • Integration of transcriptomic and proteomic data to create context-specific models

    • In silico prediction of phenotypic consequences of uxaB modifications

  • Multi-omics Data Integration:

    • Correlation analysis across transcriptomics, proteomics, and metabolomics datasets

    • Network inference to identify regulatory relationships affecting uxaB expression

    • Temporal profiling during adaptation to environmental changes (e.g., aerobic-anaerobic transitions)

    • Comparative analysis across multiple B. thetaiotaomicron strains and growth conditions

  • Pathway-focused Investigation:

    • Metabolic flux analysis using isotope labeling to track carbon flow through uxaB-related pathways

    • Targeted metabolomics of altronate metabolism intermediates

    • Enzyme complex characterization using proteomics and interactomics

    • Systematic gene deletion studies to map genetic interactions with uxaB

  • Ecological Context Integration:

    • Community-level metabolic modeling including B. thetaiotaomicron and other gut microbes

    • Analysis of cross-feeding relationships dependent on uxaB activity

    • Examination of competitive fitness in complex microbial communities

    • Host-microbe metabolic interactions influenced by altronate metabolism

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.